Carotid artery surgery improves ocular blood flow in OIS

Article

Cartotid artery surgery significantly improves ocular blood flow in patients with acute and chronic forms of ocular ishaemic syndrome (OIS), claims a study in Eye.

Carotid artery surgery significantly improves ocular blood flow in patients with acute and chronic forms of ocular ishaemic syndrome (OIS), claims a study in Eye.

Dr V. V. Neroev et al., The Helmholtz Moscow Research Institute of Eye Diseases, Moscow, Russia, conducted a study on 180 patients with OIS. Of the participants, 104 had acute forms of OIS and 76 had chronic OIS.

All patients were assessed preoperatively and six and twelve months postoperatively. The outcome measures included visual acuity, electrophysiological investigations (the threshold of electrical sensitivity (TES) and the level of liability of optic nerve (LON)) and blood flow in orbital vessels.

TES and LON improved postoperatively and visual acuity increased in patients with acute OIS. At six and twelve months postoperatively, the mean indices of blood-flow velocities in the ophthalmic artery, the central retinal artery and the posterior ciliary arteries increased.

The abstract can be found here.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.